PMC:7402624 / 641-903 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":11,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"bgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. These analyses identified three “immunotypes” associated with poor clinical "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T12","span":{"begin":22,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"bgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. These analyses identified three “immunotypes” associated with poor clinical "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T5","span":{"begin":11,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0046649"}],"text":"bgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. These analyses identified three “immunotypes” associated with poor clinical "}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":68,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"bgroup had lymphocyte activation comparable to uninfected subjects. Stable versus dynamic immunological signatures were identified and linked to trajectories of disease severity change. These analyses identified three “immunotypes” associated with poor clinical "}